|
Note 5 - Acquisition (Details) (Alpine Biosciences, Inc. [Member], USD $)
|
0 Months Ended |
3 Months Ended |
9 Months Ended |
|
Aug. 08, 2014
|
Dec. 31, 2014
|
Dec. 31, 2014
|
| Note 5 - Acquisition (Details) [Line Items] |
|
|
|
| Business Acquisition Equity Interest Issued or Issuable Pecentage of Equity |
10.00% |
|
|
| Business Acquisition, Equity Interest Issued or Issuable, Value Assigned |
$ 27,200,000 |
|
|
| Business Acquisition, Share Price (in Dollars per share) |
$ 2.93 |
|
|
| Percentage Of Acquisition Consideration For Indemnification Obligations |
12.50% |
|
|
| Indefinite-lived Intangible Assets Acquired |
19,700,000 |
|
|
| Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent |
6,908,000 |
|
|
| Business Combination, Acquisition Related Costs |
|
$ 500,000 |
$ 12,000,000 |
|
Minimum [Member]
|
|
|
|
| Note 5 - Acquisition (Details) [Line Items] |
|
|
|
| Indefinite-Lived Intangible Asset Valuation Discount Rate |
40.00% |
|
|
|
Maximum [Member]
|
|
|
|
| Note 5 - Acquisition (Details) [Line Items] |
|
|
|
| Indefinite-Lived Intangible Asset Valuation Discount Rate |
60.00% |
|
|